Cargando…
Cidofovir in the treatment of poxvirus infections
Cidofovir [(S)-1-(3-hydroxy-2-phosphonylmethoxypropyl)cytosine, HPMPC] has since 1996 been licensed for clinical use in the treatment of cytomegalovirus (CMV) retinitis in AIDS patients. Cidofovir has broad-spectrum activity against virtually all DNA viruses, including herpes-, adeno-, polyoma-, pap...
Autor principal: | De Clercq, Erik |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Science B.V.
2002
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9533828/ https://www.ncbi.nlm.nih.gov/pubmed/12076747 http://dx.doi.org/10.1016/S0166-3542(02)00008-6 |
Ejemplares similares
-
Cidofovir in the therapy and short-term prophylaxis of poxvirus infections
por: De Clercq, Erik
Publicado: (2002) -
Cidofovir Activity against Poxvirus Infections
por: Andrei, Graciela, et al.
Publicado: (2010) -
Cidofovir for the Treatment of Molluscum Contagiosum Virus
por: De Clercq, Erik
Publicado: (2022) -
Historical Perspectives in the Development of Antiviral Agents Against Poxviruses
por: De Clercq, Erik
Publicado: (2010) -
Therapeutic strategies for human poxvirus infections: Monkeypox (mpox), smallpox, molluscipox, and orf
por: De Clercq, Erik, et al.
Publicado: (2023)